Anorexigenic effect of cholecystokinin is lost but that of cart (cocaine and amphetamine regulated transcript) peptide is preserved in monosodium glutamate obese mice

Physiological Research

Volumn 58, Issue 5, 2009, Pages 717-723

  Zelezna B ^a   Maixnerova J ^a   Matyskova R ^a   Haugvicova R ^b   Blokesova D ^a   Maletinska L ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Cholecystokinin (CCK); Cocaine and amphetamine regulated transcript (CART) peptide; Monosodium glutamate (MSG) obesity; Neuropeptide Y (NPY)

Indexed keywords

CHOLECYSTOKININ; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; GLUTAMATE SODIUM; NERVE PROTEIN; NEUROPEPTIDE Y;

ANIMAL; ARCUATE NUCLEUS; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FOOD INTAKE; MALE; MOUSE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APPETITE REGULATION; ARCUATE NUCLEUS; CHOLECYSTOKININ; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEUROPEPTIDE Y; OBESITY; SODIUM GLUTAMATE;

EID: 72649092526     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Broberger C: Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Res 848: 101-113, 1999.
2. Broberger C: Brain regulation of food intake and appetite: molecules and networks. J Intern Med 258: 301-327, 2005.
3. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T: The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95: 15043-15048, 1998.
4. Broberger C, Visser TJ, Kuhar MJ, Hokfelt T: Neuropeptide Y innervation and neuropeptide-Y-Y1- receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology 70: 295-305, 1999.
5. Broberger C, Hokfelt T: Hypothalamic and vagal neuropeptide circuitries regulating food intake. Physiol Behav 74: 669-682, 2001.
6. Buettner R, Scholmerich J, Bollheimer LC: High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 15: 798-808, 2007.
7. Butler AA, Cone RD: Knockout models resulting in the development of obesity. Trends Genet 17: S50-S54, 2001.
8. Casper R, Sullivan EL, Tecott L: Relevance of animal models to human eating disorders and obesity. Psychopharmacology 199: 313-329, 2008.
9. Cawthorne MA: Opportunities and challenges for the development of pharmacological therapies for obesity treatment. Obes Rev 8 (Suppl 1): 131-136, 2007.
10. Coll AP, Farooqi S, O'rahilly SO: The hormonal control of food intake. Cell 129: 251-262, 2007.
11. Cummings DE, Overduin J: Gastrointestinal regulation of food intake. J Clin Invest 117: 13-23, 2007.
12. Dawson R, Pelleymounter MA, Miillard WJ, Liu S, Eppler B: Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol 273: E202-E206, 1997.
13. Djazayery A, Miller DS, Stock MJ: Energy balances in obese mice. Nutr Metab 23: 357-367, 1979.
14. Edelstein K, Pfaus JG, Rusak B, Amir S: Neonatal monosodium glutamate treatment prevents effects of constant light on circadian temperature rhythms of adult rats. Brain Res 675: 135-142, 1995.
15. Elefteriou F, Takeda S, Liu X, Armstrong D, Karsenty G: Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass. Endocrinology 144: 3842-3847, 2003.
16. Elmquist JK, Elias CF, Saper CB: From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22: 221-232, 1999.
17. Kerkérian L, Pelletier G: Effects of monosodium L-glutamate administration on neuropeptide Y-containing neurons in the rat hypothalamus. Brain Res 369: 388-390, 1986.
18. King PJ: The hypothalamus and obesity. Curr Drug Targets 6: 225-240, 2005.
19. Kristensen P, Judge ME, Thim L, Ribel U, Christiansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S: Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393: 72-76, 1998.
20. Lambert PD, Couceyro PR, MC Girr KM, Dall Vechia SE, Smith Y, Kuhar MJ: Cart peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29: 293-298, 1998.
21. Luckman SM, Lawrence CB: Anorectic brainstem peptides: more pieces to the puzzle. Trends Endocrinol Metab 14: 60-65, 2003.
22. Maletínská L, Shamas Toma R, Pirnik Z, Kiss A, Slaninová J, Haluzík M, Železná B: Effect of cholecystokinin on feeding is attenuated in monosodium glutamate obese mice. Reg Peptides 136: 58-63, 2006.
23. Maletínská L, Maixnerová J, Matyšková R, Haugvicová R, Šloncová E, Elbert T, Slaninová J, Železná B: Cocaine- and amphetamine-regulated transcript (CART) peptide specific binding in pheochromocytoma cells PC12. Eur J Pharmacol 559: 109-104, 2007.
24. Mcminn JE, Baskin DG, Schwartz MW: Neuroendocrine mechanisms regulating food intake and body weight. Obesity Rev. 1: 37-46, 2000a.
25. Mcminn JE, Sindelar DK, Havel PJ, Schwartz MW: Leptin deficiency induced by fasting impairs the satiety response to cholecystokinin. Endocrinology 141: 4442-4448, 2000b.
26. Mistlberger RE, Anthe MC: Neonatal monosodium glutamate alters circadian organization of feeding, food anticipatory activity and photic masking in the rat. Brain Res 842: 73-83, 1999.
27. Morris MJ, Tortelli CF, Filippis A, Proietto J: Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat. Reg Peptides 75-76: 441-447, 1998.
28. Morton GJ, Niswender KD, Rhodes CJ, Myers Jr MG, Blevins JE, Baskin DG, Schwartz MW: Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fak/fak) rats. Endocrinology 144: 2016-2024, 2003.
29. Morton GJ, Blevins JE, Williams DL, Niswender KD, Gelling RW, Rhodes CJ, Baskin DG, Schwartz MW: Leptin action in the forebrain regulates the hindbrain response to satiety signals. J Clin Invest 115: 703-710, 2005.
30. Olney JW: Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721, 1969.
31. Rowland NE: Peripheral and central satiety factors in neuropeptide Y-induced feeding in rats. Peptides 9: 989-992, 1988.
32. Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K, Koletsky RJ: Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 14: 130-131, 1996.
33. Tamura H, Kamegai J, Shimizu T, Ishii S, Sugihara H, Oikawa S: Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology 143: 3268-3275, 2002.
34. Tang-Christensen M, Vrang N, Larsen PJ: Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes 47: 530-537, 1998.
35. Tang-Christensen M, Holst JJ, Hartmann B, Vrang N: The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin. Neuroreport 10: 1183-1187, 1999